| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 09/07/2012 | 20:41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 05/07/2012 | 22:03 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 02/07/2012 | 21:18 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 28/06/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Announces Name Change to MEI Pharma ("MEIP") | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 04/06/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143 | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 29/05/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 25/05/2012 | 19:32 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 15/05/2012 | 16:05 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 14/05/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Completes Rights Offering To Stockholders | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 08/05/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 25/04/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 10/04/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat... | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 03/04/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual Meeting | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 28/03/2012 | 15:00 | PR Newswire (US) | Marshall Edwards CEO to Present at Needham Healthcare Conference | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 27/03/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Receives Notice of Effectiveness for Rights Offering to Stockholders | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 27/03/2012 | 12:02 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 20/03/2012 | 13:55 | Edgar (US Regulatory) | Securities Registration Statement (S-1/A) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 19/03/2012 | 14:00 | PR Newswire (US) | Marshall Edwards Announces Terms for Rights Offering to Stockholders | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 06/03/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344 | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 29/02/2012 | 15:00 | PR Newswire (US) | Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 21/02/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Announces Rights Offering to Stockholders | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 21/02/2012 | 12:57 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 21/02/2012 | 12:11 | Edgar (US Regulatory) | Securities Registration Statement (S-1) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 14/02/2012 | 22:12 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 03/01/2012 | 15:00 | PR Newswire (US) | Marshall Edwards Issued New Method of Use Patent for Lead Oncology Drug Candidate ME-344 | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 29/12/2011 | 15:00 | PR Newswire (US) | Marshall Edwards Adds $2 Million in Private Placement | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 20/12/2011 | 15:00 | PR Newswire (US) | Marshall Edwards Awarded Key Patent For Compositions Of Lead Oncology Drug Candidates | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 22/11/2011 | 15:00 | PR Newswire (US) | Marshall Edwards to Host Annual Meeting of Stockholders | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 10/11/2011 | 15:00 | PR Newswire (US) | Marshall Edwards CEO to Present at Lazard Capital Markets Healthcare Conference | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |
| 28/10/2011 | 17:44 | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:MSHL | Mei Pharma, Inc. (MM) |